Skip to main content

Išsėtinės sklerozės įvertinimo žodynėlis

Išsėtinė sklerozė

Nėra vieno tyrimo, kuris išsamiai įvertintų išsėtinę sklerozę (IS) Šiame žodynėlyje pateikiami paprasti kai kurių IS apibūdinti vartojamų terminų paaiškinimai.

CDP – Patvirtintas negalios progresavimas (angl. Confirmed Disability Progression)

Parodo paciento išplėstinės negalios vertinimo skalės (angl. EDSS) įvertinimo balo (žr. toliau) padidėjimą, kuris išlieka per iš anksto apibrėžtą laikotarpį, o tai reiškia, kad paciento fizinė negalia pablogėjo.3

Apie išsėtinę sklerozę per 40 sekundžių

Literatūros sąrašas:

  1. Multiple Sclerosis Coalition. The Use Of Disease – Modifying Therapies In Multiple Sclerosis: Principles and Current Evidence Summary. Available at https://www.nationalmssociety.org/getmedia/1e64b96c-9e55-400e-9a64-0cdf5e2d60fe/summaryDMTpaper_-final.   Accessed September 2016.

  2. Bermel, RA, et al. The measurement and clinical relevance of brain atrophy in multiple sclerosis. The Lancet Neurology. 2006; 5(2):158 – 170.

  3. Wiendl H, Meuth SG. Pharmacological Approaches to Delaying Disability Progression in Patients with Multiple Sclerosis. Drugs. 2015;75(9):947-977.

  4. Giovannoni, G, et al. Brain Health: Time Matters in Multiple Sclerosis. 2015; pp 14.

  5. Lublin FD, et al. Defining the clinical course of multiple sclerosis. Neurology. 2014; 83(3):278 – 86.

  6. National MS Society. Functional Systems Score (FSS) and Expanded Disability Status Scale. Available at https://www.nationalmssociety.org/For-Professionals/Researchers/Resources-for-Researchers/Clinical-Study-Measures/Functional-Systems-Scores-(FSS)-and-Expanded-Disab.

    Accessed September 2016.

  7. National MS Society. Magnetic Resonance Imaging (MRI). Available at https://www.nationalmssociety.org/Symptoms-Diagnosis/DiagnosingTools/MRI.  

    Accessed September 2016.

  8. National MS Society. Multiple Sclerosis Functional Composite (MSFC). Available at https://www.nationalmssociety.org/For-Professionals/Researchers/Resources-for-Researchers/Clinical-Study-Measures/Multiple-Sclerosis-Functional-Composite-(MSFC).

    Accessed September 2016.

  9. MS Society UK. NEDA (no evidence of disease activity). Available at  https://www.mstrust.org.uk/a-z/neda-no-evidencedisease-activity. Accessed September 2016.

  10. National MS Society. 9-Hole Peg Test (9-HPT). Available at https://www.nationalmssociety.org/For-Professionals/Researchers/Resources-forResearchers/Clinical-Study-Measures/9-Hole-Peg-Test-(9-HPT).

    Accessed September 2016.

  11. National MS Society. Paced Auditory Serial Addition Test (PASAT). Available at https://www.nationalmssociety.org/For-Professionals/Researchers/Resources-for-Researchers/Clinical-Study-Measures/Paced-Auditory-Serial-Addition-Test-(PASAT).

    Accessed September 2016.

  12. National MS Society. Managing Relapses. Available at  https://www.nationalmssociety.org/Treating-MS/Managing-Relapses. Accessed September 2016.

  13. National MS Society. Timed 25-Foot Walk (T25-FW). Available at https://www.nationalmssociety.org/For-Professionals/Researchers/Resources-for-Researchers/Clinical-Study-Measures/Timed-25-Foot-Walk-(T25-FW).

    Accessed September 2016.

  14. Sethi V, et al. Slowly eroding lesions in multiple sclerosis. Mult Scler. 2017 Mar;23(3):464-472.

Parsisiųsti

Download Infografikas: Išsėtinės sklerozės įvertinimo žodynėlis

PDF